PDL BioPharma (PDLI) Announces Significant Strategic and Portfolio Changes; Hires Merrill Lynch to Advise
Tweet Send to a Friend
PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) announced a significant strategic change to focus the company on the discovery and development ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
